Donors were HLA-matched sibling or matched unrelated (10/10)
Donors were HLA-matched sibling or matched unrelated (10/10). (64%) 6 of 42 (14.2%) before HSCT. With a median follow-up of 36 months (range, 19-53), 3-12 months overall survival, non-relapse mortality and cumulative incidence of relapse are 86.9% (95% Confidence Interval [CI]: 70.8-94.4), 9.5% (95% CI: 3.7-23.4) and 29.6% (95% CI: 17.3-47.7). Incidence of 2-12 months…